Berman Howard 4
4 · Coya Therapeutics, Inc. · Filed Jan 13, 2025
Insider Transaction Report
Form 4
Berman Howard
DirectorExecutive Chairman
Transactions
- Award
Stock Option (right to buy)
2025-01-09+150,602→ 150,602 totalExercise: $6.07Exp: 2035-01-09→ Common Stock, par value $0.0001 per share (150,602 underlying)
Footnotes (1)
- [F1]The option will vest in monthly installments over 36 months commencing on February 9, 2025, subject to continuous service on each vesting date.